PsychonautWiki Archive

NM-2-AI: Difference between revisions

← Older edit
>Dextromethorphan
legality switzerland
>David Hedlund
{{#set:Featured=true}}
 
(4 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{{SummarySheet}}
{{SummarySheet}}
{{SubstanceBox/N-methyl-2-AI}}
{{SubstanceBox/NM-2-AI}}


'''NM-2-AI''' ('''N-methyl-2-aminoindane''') is a [[psychoactive drug]] and [[research chemical]] with [[psychoactive class::stimulant]] properties of the [[Chemical class::aminoindane]] chemical class.
'''NM-2-AI''' ('''N-methyl-2-aminoindane''') is a lesser-known novel [[psychoactive class::stimulant]] substance of the [[Chemical class::aminoindane]] class. It is structurally related to [[2-AI]] and [[MDAI]].
 
In comparison to [[2-AI]], this compound has a lower potency, a longer duration and very similar effects. It has recently become easily accessible  through online [[research chemical]] vendors where it is sold as a [[designer drug]].
 
Very little data exists for the effects, pharmacology, and toxicity of NM-2-AI. It is highly advised to use [[harm reduction practices]] if using this substance.


In comparison to the more prevalent close chemical relative known as [[2-AI]], this compound has a lower potency, a longer duration and very similar effects. Besides this, very little is known about this substance. It has recently become easily accessible  through online [[research chemical]] vendors where it is sold as a [[designer drug]].
==Chemistry==
==Chemistry==
NM-2-AI, or N-methyl-2-AI, is the N-methylated derivative of [[2-Aminoindane]] and is analogous to [[amphetamine]]. It features the R<sub>3</sub> terminal carbon of the propane chain of amphetamine bound to the benzene ring. This creates an indane, a bicycle containing a benzene ring fused to a pentane ring. The amino group 2-AI shares with amphetamine is bound to R<sub>2</sub> of the indane group. N-methyl-2-AI contains a methyl group bound to the amino group R<sub>N</sub> (for which it is named).
NM-2-AI, or N-methyl-2-AI, is the N-methylated derivative of [[2-Aminoindane]] and is analogous to [[amphetamine]]. It features the R<sub>3</sub> terminal carbon of the propane chain of amphetamine bound to the benzene ring. This creates an indane, a bicycle containing a benzene ring fused to a pentane ring. The amino group 2-AI shares with amphetamine is bound to R<sub>2</sub> of the indane group. N-methyl-2-AI contains a methyl group bound to the amino group R<sub>N</sub> (for which it is named).
Line 54: Line 57:
}}
}}


}}


 
===Experience reports===
}}
Anecdotal reports which describe the effects of this compound within our [[experience index]] include:
{{#ask: [[Category:NM-2-AI]][[Category:Experience]]|format=ul|Columns=1}}


==Toxicity and harm potential==
==Toxicity and harm potential==
Line 70: Line 75:
===Psychosis===
===Psychosis===
{{Main|Stimulant psychosis}}
{{Main|Stimulant psychosis}}
Abuse of compounds within the stimulant class at high dosages for prolonged periods of time can potentially result in a stimulant psychosis that may present with a variety of symptoms (e.g., [[Paranoia|paranoia]], [[External hallucinations|hallucinations]], or [[Delusions|delusions]]).<ref name="Shoptaw2009">[http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD003026.pub3/abstract?systemMessage=Wiley+Online+Library+will+be+disrupted+Saturday%2C+15+March+from+10%3A00-12%3A00+GMT+%2806%3A00-08%3A00+EDT%29+for+essential+maintenance "Treatment for amphetamine psychosis"]</ref> A review on treatment for amphetamine, [[dextroamphetamine]], and [[methamphetamine]] abuse-induced psychosis states that about 5–15% of users fail to recover completely.<ref name="Shoptaw2009"></ref><ref>Hofmann FG (1983). A Handbook on Drug and Alcohol Abuse: The Biomedical Aspects (2nd ed.). New York: Oxford University Press. p. 329. ISBN 9780195030570.</ref> The same review asserts that, based upon at least one trial, [[antipsychotic]] medications effectively resolve the symptoms of acute amphetamine psychosis.<ref name="Shoptaw2009"></ref>
Abuse of compounds within the stimulant class at high dosages for prolonged periods of time can potentially result in a stimulant psychosis that may present with a variety of symptoms (e.g., [[Paranoia|paranoia]], [[External hallucinations|hallucinations]], or [[Delusions|delusions]]).<ref name="Shoptaw2009">{{cite journal | vauthors=((Shoptaw, S. J.)), ((Kao, U.)), ((Ling, W.)) | veditors=((Cochrane Drugs and Alcohol Group)) | journal=Cochrane Database of Systematic Reviews | title=Treatment for amphetamine psychosis | date=21 January 2009 | url=https://doi.wiley.com/10.1002/14651858.CD003026.pub3 | issn=14651858 | doi=10.1002/14651858.CD003026.pub3}}</ref> A review on treatment for amphetamine, [[dextroamphetamine]], and [[methamphetamine]] abuse-induced psychosis states that about 5–15% of users fail to recover completely.<ref name="Shoptaw2009"></ref><ref>{{cite book | vauthors=((Hofmann, F. G.)) | date= 1983 | title=A handbook on drug and alcohol abuse: the biomedical aspects | publisher=Oxford University Press | edition=2nd ed | isbn=9780195030563}}</ref> The same review asserts that, based upon at least one trial, [[antipsychotic]] medications effectively resolve the symptoms of acute amphetamine psychosis.<ref name="Shoptaw2009"></ref>


===Dangerous interactions===
===Dangerous interactions===
Line 82: Line 87:
*'''[[Cocaine]]''' - This combination may increase strain on the heart.
*'''[[Cocaine]]''' - This combination may increase strain on the heart.


==Legal issues==
==Legal status==
{{legalStub}}
{{legalStub}}
NM-2-AI is currently believed to be a grey area compound within most parts of the world. This means that it is not known to be specifically illegal within any country but people may still be charged for its possession under certain circumstances such as under analogue laws and with intent to sell or consume.
NM-2-AI is currently believed to be a grey area compound within most parts of the world. This means that it is not known to be specifically illegal within any country but people may still be charged for its possession under certain circumstances such as under analogue laws and with intent to sell or consume.
Line 88: Line 93:
*'''Germany''': NM-2-AI is controlled under the NpSG (''New Psychoactive Substances Act'')<ref>{{cite web|url=https://www.gesetze-im-internet.de/npsg/anlage.html|title=Anlage NpSG|publisher=Bundesministerium der Justiz und für Verbraucherschutz|access-date=December 23, 2019|language=de}}</ref> as of November 26, 2016.<ref>{{cite web|url=https://www.bgbl.de/xaver/bgbl/start.xav?startbk=Bundesanzeiger_BGBl&jumpTo=bgbl116s2615.pdf#__bgbl__%2F%2F*%5B%40attr_id%3D%27bgbl116s2615.pdf%27%5D__1576017393518|title=Gesetz zur Bekämpfung der Verbreitung neuer psychoaktiver Stoffe|publisher=Bundesanzeiger Verlag|access-date=December 23, 2019|language=de}}</ref> Production and import with the aim to place it on the market, administration to another person and trading is punishable. Possession is illegal but not penalized.<ref>{{cite web|url=https://www.gesetze-im-internet.de/npsg/__4.html|title=§ 4 NpSG|publisher=Bundesministerium der Justiz und für Verbraucherschutz|access-date=December 23, 2019|language=de}}</ref>
*'''Germany''': NM-2-AI is controlled under the NpSG (''New Psychoactive Substances Act'')<ref>{{cite web|url=https://www.gesetze-im-internet.de/npsg/anlage.html|title=Anlage NpSG|publisher=Bundesministerium der Justiz und für Verbraucherschutz|access-date=December 23, 2019|language=de}}</ref> as of November 26, 2016.<ref>{{cite web|url=https://www.bgbl.de/xaver/bgbl/start.xav?startbk=Bundesanzeiger_BGBl&jumpTo=bgbl116s2615.pdf#__bgbl__%2F%2F*%5B%40attr_id%3D%27bgbl116s2615.pdf%27%5D__1576017393518|title=Gesetz zur Bekämpfung der Verbreitung neuer psychoaktiver Stoffe|publisher=Bundesanzeiger Verlag|access-date=December 23, 2019|language=de}}</ref> Production and import with the aim to place it on the market, administration to another person and trading is punishable. Possession is illegal but not penalized.<ref>{{cite web|url=https://www.gesetze-im-internet.de/npsg/__4.html|title=§ 4 NpSG|publisher=Bundesministerium der Justiz und für Verbraucherschutz|access-date=December 23, 2019|language=de}}</ref>
*'''Switzerland''': NM-2-AI is a controlled substance specifically named under Verzeichnis E.<ref>{{cite web|url=https://www.admin.ch/opc/de/classified-compilation/20101220/index.html|title=Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien|publisher=Bundeskanzlei [Federal Chancellery of Switzerland]|access-date=January 1, 2020|language=de}}</ref>
*'''Switzerland''': NM-2-AI is a controlled substance specifically named under Verzeichnis E.<ref>{{cite web|url=https://www.admin.ch/opc/de/classified-compilation/20101220/index.html|title=Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien|publisher=Bundeskanzlei [Federal Chancellery of Switzerland]|access-date=January 1, 2020|language=de}}</ref>
*'''United Kingdom''': It is illegal to produce, supply, or import this drug under the Psychoactive Substance Act, which came into effect on May 26th, 2016.<ref>Psychoactive Substances Act 2016 (Legislation.gov.uk) | http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted</ref>
*'''United Kingdom''': It is illegal to produce, supply, or import this drug under the Psychoactive Substance Act, which came into effect on May 26th, 2016.<ref>{{Citation | title=Psychoactive Substances Act 2016 | url=https://www.legislation.gov.uk/ukpga/2016/2/contents/enacted}}</ref>


==See also==
==See also==
*[[Responsible use]]
*[[Responsible use]]
*[[2-AI]]
*[[2-AI]]
Line 110: Line 114:
[[Category:Aminoindane]]
[[Category:Aminoindane]]
[[Category:Research chemical]]
[[Category:Research chemical]]
{{#set:Featured=true}}
Retrieved from "http://psy.st/wiki/NM-2-AI"